Skip to content

Comparing the effectiveness of cognitive therapy based on mindfulness and metacognitive therapy on psychological-social-cognitive factors in women with mastectomy breast cancer.

Comparing the effectiveness of cognitive therapy based on mindfulness and metacognitive therapy on psychological-social-cognitive factors in women with mastectomy breast cancer.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20241006063268N1
Enrollment
60
Registered
2024-10-17
Start date
2024-10-08
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer-mastectomy surgery.

Interventions

Intervention 1: Intervention group: Mindfulness-Based Cognitive Therapy (MBCT)Overview: MBCT integrates cognitive behavioral therapy (CBT) techniques with mindfulness practices. It aims to help indivi

Sponsors

The University Of Urmia
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
35 Years to 55 Years

Inclusion criteria

Inclusion criteria: Women aged 35 to 55 who have undergone unilateral or bilateral mastectomy. Participants must have completed their course of chemotherapy and/or radiation therapy at least three months prior to the study, showing improvement after treatment. Participants should not have a history of psychotherapy or drug treatment for mental disorders prior to the study. Participants must not have undergone breast reconstruction surgery. Participants must be able to understand and provide informed consent to participate in the study. Participants must have the cognitive ability to participate in therapy sessions and complete assessments.

Exclusion criteria

Exclusion criteria: Participants who miss more than two treatment sessions without valid justification will be excluded from the study. Participants who voluntarily withdrew from the study before completing treatment or assessments were recorded as withdrawals. Participants should be assessed at follow-up using the same psychological instruments used initially to assess changes in psychosocial-cognitive factors. Participants who experience local recurrence (reappearance of cancer in the same area of ??the breast or chest) or distant metastasis (cancer in other parts of the body) during the study will be withdrawn from the trial to ensure their health and safety.

Design outcomes

Primary

MeasureTime frame
Coping power. Timepoint: Before the start of the intervention - after the intervention - a 3-month follow-up period. Method of measurement: the silver lining questionnaire (SLQ-38).;Self-Empathy. Timepoint: Before the start of the intervention - after the intervention - a 3-month follow-up period. Method of measurement: Self-Empathy Scale (SCS-SF): Christian Neff.;Stress-Related Growth. Timepoint: Before the start of the intervention - after the intervention - a 3-month follow-up period. Method of measurement: Stress-Related Growth Scale (SRGS-SF) Short Version: Tedeschi , Calhoun (1996).;Quality of life. Timepoint: Before the start of the intervention - after the intervention - a 3-month follow-up period. Method of measurement: quality of life in adult cancer survivors (QLACS): Avis et al. (2005).;Emotional Self-Efficacy. Timepoint: Before the start of the intervention - after the intervention - a 3-month follow-up period. Method of measurement: Emotional Self-Efficacy Scale (ESES) Short Form: Qualter and Dacre (2012).;Defeat of failure. Timepoint: Before the start of the intervention - after the intervention - a 3-month follow-up period. Method of measurement: defeat of failure (DQ): Gilbert and Allen (1998).;Body acceptance. Timepoint: Before the start of the intervention - after the intervention - a 3-month follow-up period. Method of measurement: Body acceptance scale for women with breast cancer (BAS-BC): Ahn and Suh (2018).

Countries

Iran (Islamic Republic of)

Contacts

Public Contacthanie pakravan

The University of Urmia

hanie.pakravan@gmail.com+98 44 3275 2741

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026